StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Tuesday morning.
TCMD has been the subject of several other reports. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. BTIG Research downgraded Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th. Finally, B. Riley assumed coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They set a “buy” rating and a $23.00 target price on the stock.
Check Out Our Latest Research Report on Tactile Systems Technology
Tactile Systems Technology Trading Up 1.6 %
Institutional Trading of Tactile Systems Technology
Hedge funds have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD increased its holdings in shares of Tactile Systems Technology by 7.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 17,371 shares of the company’s stock worth $283,000 after acquiring an additional 1,159 shares during the last quarter. Arcadia Investment Management Corp MI acquired a new position in shares of Tactile Systems Technology in the third quarter valued at $29,000. ClariVest Asset Management LLC raised its position in shares of Tactile Systems Technology by 2.9% in the second quarter. ClariVest Asset Management LLC now owns 83,195 shares of the company’s stock valued at $993,000 after purchasing an additional 2,326 shares during the period. Gladius Capital Management LP acquired a new stake in shares of Tactile Systems Technology during the 3rd quarter worth about $44,000. Finally, Quarry LP bought a new stake in shares of Tactile Systems Technology during the 2nd quarter worth about $46,000. 83.43% of the stock is owned by institutional investors and hedge funds.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- Ride Out The Recession With These Dividend Kings
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Netflix Is On Track To Hit $1,000 By Christmas
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.